Testing effectiveness (Phase 2)Study completedNCT00542308What this trial is testingZalutumumab in Non-curable Patients With SCCHNWho this might be right forHead and Neck CancerSquamous Cell Cancer Genmab 90
Not applicableLooking for participantsNCT06678724What this trial is testingEstablishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA ChipWho this might be right forHead and Neck Cancers- Squamous CellHead and Neck Cancer MetastaticRecurrent Head and Neck Squamous Cell Carcinoma National Taiwan University Hospital 30
Early research (Phase 1)Study completedNCT02544880What this trial is testingPDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCCWho this might be right forHead and Neck Squamous Cell CarcinomaHead and Neck Cancer Donald T. Weed, MD, FACS 16
Not applicableUnknownNCT00766480What this trial is testingStudy of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the EsophagusWho this might be right forEsophageal Cancer University of Toyama 160
Early research (Phase 1)Study completedNCT04291079What this trial is testingSRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)Who this might be right forCancer Scholar Rock, Inc. 112
Not applicableUnknownNCT03588403What this trial is testingTOMO Versus IMRT in Nasopharyngeal Carcinoma PatientsWho this might be right forNasopharyngeal Carcinoma Zhejiang Cancer Hospital 110
Very early researchWithdrawnNCT06086925What this trial is testingA Window of Opportunity Study of Black Raspberry for Patients With HNSCCWho this might be right forSquamous Cell Carcinoma of the Oral Cavity or Oropharynx Mitchell Machtay
Not applicableStudy completedNCT00899340What this trial is testingProtein Expression in Tumor Tissue Samples From Patients With Cancer of the OropharynxWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00055913What this trial is testingBevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more National Cancer Institute (NCI) 58
Early research (Phase 1)Active Not RecruitingNCT02495896What this trial is testingRecombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more University of Southern California 61
Early research (Phase 1)Study completedNCT02254018What this trial is testingSingle Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Neoplasms Boehringer Ingelheim 31
Testing effectiveness (Phase 2)UnknownNCT05596890What this trial is testingPatient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer PatientsWho this might be right forEsophageal Squamous Cell CarcinomaPatient-reported OutcomesImmunotherapy Guangdong Provincial People's Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06509997What this trial is testingA Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma Lei Liu 30
Early research (Phase 1)Study completedNCT04069026What this trial is testingA First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced CancerWho this might be right forAdvanced Solid Tumors Bayer 78
Not applicableStudy completedNCT03081715What this trial is testingPD-1 Knockout Engineered T Cells for Advanced Esophageal CancerWho this might be right forEsophageal Cancer Hangzhou Cancer Hospital 16
Not applicableLooking for participantsNCT06821243What this trial is testingPatients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical InterventionWho this might be right forSquamous Cell Carcinoma of Oropharynx Regina Elena Cancer Institute 40
Not applicableStudy completedNCT05049408What this trial is testingVerification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity CancerWho this might be right forOral Squamous Cell Carcinoma S&T Biomed Co., Ltd. 1,160
Testing effectiveness (Phase 2)Ended earlyNCT04634825What this trial is testingEnoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck CancerWho this might be right forHead and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma MacroGenics 62
Early research (Phase 1)Looking for participantsNCT05859074What this trial is testingMQ710 With and Without Pembrolizumab in People With Solid Tumor CancerWho this might be right forCutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT00188318What this trial is testingHardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)Who this might be right forCarcinoma, Squamous Cell University Health Network, Toronto 169